FDG-PET/CT fusion scan of the body showing osseous (bony) thoracic (T6) and lumbar (L5) metastases from lung cancer, frontal section. FDG (F-labeled 2-deoxyglucose) is a radiopharmaceutical used to differentiate between benign and canceroustumors by reflecting glucose uptake.
Credit
ISM
/ Centre Jean PERRIN
Dimensions
2639 x 3543 pixels
Print Size @ 300 dpi
9 x 12 inches / 22 x 30 cm